Although the expression of MARCO in testicular cancer, cervical cancer, melanoma, thyroid cancer, brain cancer, and renal cancer increased, there were fewer fold changes than in pancreatic cancer (Figure 5A). This evidence concerns the gene MARCO and thyroid gland carcinoma.